DICE方案治疗97例复发／难治非霍奇金淋巴瘤患者的疗效及生存分析

OBJECTIVE: To investigate the efficacy and survival of the DICE regimen (cisplatin, ifosfamide, etoposide, dexamethasone) for relapsed and refractory NHL. METHODS: Clinical data of 97 relapsed and refractory NHL patients treated with DICE regimen in Peking University Cancer Hospital between Sep 1. 2...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342104/
https://www.ncbi.nlm.nih.gov/pubmed/27719723
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342104/
https://www.ncbi.nlm.nih.gov/pubmed/27719723
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.09.012

Ejemplares similares